期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血管紧张肽Ⅱ受体拮抗药的药理作用与临床应用 被引量：1

下载PDF
导出
摘要 综述血管紧张肽Ⅱ受体拮抗药的药理作用 ,系统地论述其在心血管疾病方面的临床应用进展。
作者 蓝神林
机构地区 湖北省监利县人民医院心血管内科
出处 《医药导报》 CAS 2005年第1期53-55,共3页 Herald of Medicine
关键词 血管紧张肽Ⅱ受体拮抗药 心血管疾病
分类号 R972 [医药卫生—药品]
  • 相关文献

参考文献14

  • 1李庚山.血管紧张素转换酶抑制剂及血管紧张素受体拮抗剂在心力衰竭治疗中的应用[J].内科急危重症杂志,2000,6(3):145-147. 被引量：4
  • 2Schmitz D, Berk B C. Angiotensin Ⅱ signal transduction stimulation of multiple mitogen activated protein kinase pathways[J]. Trendsendocrinol Metab, 1997,8 ( 2 ) :261 - 266.
  • 3Joel M, Neutel M D, Martin P,et al. Efficacy of valsartan in patients aged≥65 years with systolic hypertension[J]. Clin Ther, 2000 ,22(8) :961-969.
  • 4Allen D , Charles B, David P. A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or an angiotensin-converting enzyme inhibitor or angiotensin Ⅱ rceptor blocker [ J ]. Clin Ther, 2002, 24 ( 6 ) :930 - 942.
  • 5Nobuo T , Nobuhisa A , Katsuhito T. A single-center, open-label, randomized, parallel-group study assessing the differences between an angiotensin 1I receptor antagonist and an angiotensin-converting enzyme inhibitorin hypertensive patients with congestive heart failure : the research for efficacy of angiotensin Ⅱ receptor antagonist in hypertensive patients with congestive heart failure study [ J ]. Curr Ther Res, 2003,64(2) : 81 -95.
  • 6Salim Y , Dphil . From the hope to the ontarget and the transcendstudies: challenges in improving prognosis[ J]. Am J Cardiol, 2002, 89 (2) :560-565.
  • 7Pitt B. Randomised trial of losartan versus captopril in patients over 65 with heart failure ( evaluation of losartan in the elderly, eliet) [ J ]. Lancet, 1997,349:747.
  • 8Stephen G, Ball M D, William B ,et al. Debate: angiotensinconverting enzyme inhibitors versus angiotensin Ⅱ receptor blockers-a gap in evidence-based medicine[ J]. Am J Cardiol,2003, 91 (10) :15 -21.
  • 9Coats A J. Angiotensin type-1 receptor blockers in heart failure[J]. Prog Cardiovasc Dis, 2002,44(4) :231 -242.
  • 10Schiffrin E L. Vascular and cardiac benefits of angiotensin rece-ptor blockers[J]. Am J Med, 2002, 113(5) :409 -418.

二级参考文献13

  • 1Gaspoz JM. Costs and benefits of heart failure treatment. SchweizMed Wochenschr, 1999,129(4):131.
  • 2Connor CM, Gattis WA, Swedberg K. Current and novel Pharma-cologic approaches in advanced heart failure. Am Heart J, 1998 ,135(6 Pt 2 Su):S249.
  • 3Coodley E. Newer drug therapy for congestive heart failure. ArchIntern Med 1999 , 159(11): 1177.
  • 4Unterberg C, Kreuzer H, Buchwald AB. The renin-angiotensin sys-tem in cardiovascular diseases. Med Klin, 1998, 93(7):416.
  • 5Garg R, Yusuf S. Overview of randomized trials of angiotensin-con-vetting enzyme inhibitors on mortality and morbidity in patients withheart failure. Collaborative Group on ACE Inhibitor Trials. JAMA,1995, 273(18): 1450.
  • 6Brunner La, Rocca HP, Vaddadi G, et al. Recent insight into ther-apy of congestive heart failure: focus on ACE inhibition and an-giotensin-Ⅱ antagonism. J Am Coll Cardiol, 1999,33(5): 1163.
  • 7Brown NJ, Vaughan DE. Angiotensin-converting enzyme in-hibitors. Circulation, 1998, 97(14):1411.
  • 8Toole L, Stewart M, Padfield P, et al. Effect of the insertion/dele-tion polymorphism of the angiotensin-converting enzyme gene on re-sponse to angiotensin-converting. J Cardiovasc Pharmacol, 1998, 32(6):988.
  • 9Van Veldhuisen DJ, Genth Zotz S, Brouwer J, et al. High-versuslow-dose ACE inhibition in chronic heart failure: a double-blind,placebo-controlled study of imidapril. J Am Coll Cardiol, 1998, 32(7): 1811.
  • 10Davie AP, AU-Dargie HJ, McMurray JJ. Role of bradykinin in thevasodilator effects of losartan and enalapril in patients with heartfailure. Circulation, 1999, 100(3):268.

共引文献3

同被引文献3

引证文献1

医药导报
2005年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部